AI now sits behind a growing share of commercial decisions in life sciences. It helps teams segment customers, prioritize accounts, recommend next best actions, and plan omnichannel engagement.
But there’s a catch.
AI can only work with the commercial reality captured in the data behind it. If that data is outdated, even a very good model can point teams in the wrong direction.
That’s becoming harder to ignore. Physicians change affiliations. Practices open, close, or move. Health systems merge. Referral patterns shift. Yet enterprise systems may continue showing an older version of those relationships.
This creates what we’ll call the Commercial Reality Gap: the difference between what’s happening in the healthcare ecosystem and what commercial systems believe is happening.
The Problem Starts Before AI
When a targeting program underperforms, the first instinct is often to look at the model.
Maybe the algorithm needs better features. Maybe there isn’t enough data. Perhaps a newer AI model would perform better.
Sometimes that’s true. But there’s an earlier question worth asking:
Is the commercial data feeding the model still accurate?
AI doesn’t know that a physician changed health systems last month unless that change is reflected in its data. It doesn’t automatically recognize that a practice now has three locations instead of one, or that an HCP’s referral relationships have changed.
It simply works with what it receives.
So an AI system can produce a perfectly reasonable recommendation based on information that no longer describes the market. The model may be functioning exactly as designed. The problem is the picture of the market underneath it.
Why Static HCP Data Is Becoming a Commercial Risk
Periodic data updates worked reasonably well when provider relationships changed slowly.
That’s not the environment commercial teams are dealing with anymore.
Physicians move between organizations. Health systems consolidate. Practices expand across locations. Telehealth changes how and where care is delivered. Referral networks evolve.
Each change can have a commercial consequence.
Take a physician joining a new health system. In a database, it might look like a simple affiliation update. For a commercial team, that one change could affect the account hierarchy, territory ownership, access strategy, and engagement plan.
If the change takes weeks or months to reach the systems used by sales and marketing, those teams are making decisions using an old version of the customer.
That’s the real issue.
When HCP Targeting Looks Right on Paper but Misses in the Field
A HCP targeting model can perform well in testing and still struggle once commercial teams use it in the real world.
Historical model accuracy doesn’t guarantee that the underlying customer information is current.
This is where Decision Drift starts to show up.
Territories may be prioritized based on relationships that have changed. Segments can become less useful. Next best action recommendations may no longer fit how an HCP practices or influences treatment decisions.
And there may be no obvious system failure.
The dashboard still loads. The model still runs. Campaigns still go out.
The problem is subtler: the decisions gradually become less relevant.
By the time commercial teams notice a drop in performance, the underlying data issue may have been around for months.
The Commercial Reality Gap Doesn't Stay in One System
HCP intelligence feeds a lot more than targeting.
Sales teams use it for territory planning and account prioritization. Marketing uses it for audience selection and engagement. Commercial operations rely on it for planning and forecasting. Analytics teams use the same information to understand customers and performance.
That creates a chain reaction.
Suppose an HCP’s affiliation is outdated. The account hierarchy may be wrong. Territory ownership can then be affected. The same record might feed segmentation, customer analytics, and campaign activation.
One stale record can travel a long way.
This is why the issue isn’t really about fixing individual HCP records. The bigger question is how quickly verified changes can move through the commercial ecosystem.
A Better Algorithm Won't Fix Stale Intelligence
When commercial performance starts slipping, organizations often respond by adding more technology.
They refine the model. Add another data source. Introduce more variables. Move to a newer AI architecture.
Those changes can help when the model itself is the problem. They won’t solve much if the underlying provider intelligence is stale.
In fact, there’s a risk of making the problem harder to spot. A sophisticated model can produce highly confident recommendations even when the relationships underneath those recommendations are outdated.
So before asking whether the organization needs a smarter model, it’s worth checking whether it has a current view of the market.
Why Traditional Master Data Management Isn't Enough
Master Data Management remains a core part of life sciences data operations. It helps establish consistent HCP records, support CRM processes, maintain governance, and give different teams a common customer view.
The limitation is timing.
Many MDM processes were built around scheduled updates and validation cycles. That approach provides structure and control, but it can struggle when provider relationships are changing continuously.
A physician can change affiliations today. The commercial system may not reflect it until the next validation cycle, after a series of checks, approvals, and downstream updates.
That delay matters.
The goal is shifting from maintaining a trusted static record to maintaining a trusted representation of an evolving healthcare ecosystem.
What Continuous HCP Intelligence Actually Requires
Continuous intelligence doesn’t simply mean running the same data process every week instead of every month.
It means watching for signals that something meaningful has changed.
Those signals can include:
physician affiliation changes
new or relocated practice locations
health system restructuring
changes in referral relationships
shifts in prescribing or care delivery patterns
When a meaningful change is detected, it should enter a validation workflow before stale information starts influencing commercial decisions.
There’s also an organizational side to this.
HCP intelligence shouldn’t sit entirely with a master data team. Sales, marketing, commercial operations, analytics, medical affairs, and IT all interact with this information. Each sees different parts of the customer picture.
A shared operating model gives those teams a way to identify changes, validate them, and push trusted updates into the systems that depend on them.
Measure How Fast the Organization Can Respond
Traditional data quality metrics still have a place. Completeness, duplication, and validation accuracy are useful measures.
But they don’t answer a question commercial leaders increasingly need to ask:
How quickly can we turn a real-world change into usable commercial intelligence?
Useful measures might include:
time taken to validate a critical HCP change
time required to synchronize the change across systems
consistency of customer records across CRM and analytics platforms
time between validation and operational availability
frequency of conflicting customer information
These measures get closer to decision readiness than a simple data-quality score does.
That distinction becomes especially important when AI is making or influencing decisions at scale.
What Two Enterprise Examples Tell Us
The source briefing highlights two examples that show why reducing data latency matters.
At Boehringer Ingelheim, fragmented master data processes created delays in getting trusted HCP reference information into CRM systems. After implementing Veeva OpenData and Veeva Network MDM, the company reduced data change request resolution time from more than one week to two or three days. The organization also moved toward standardizing customer data across more than 100 countries.
A separate global Top-10 pharmaceutical company faced conflicting customer records, slow master data processes, and delayed change requests. Its unified customer data strategy reportedly reduced data change request processing time from 40 days to a few hours, cut new data-source onboarding from 12 weeks to two weeks, connected 21 enterprise data sources, and generated more than $500,000 in annual savings.
The numbers are telling.
Moving from 40 days to a few hours isn’t just a data-management improvement. It changes how quickly commercial teams can respond when something in the market changes.
Where Commercial Analytics Fits In
The same data foundation supports more than customer targeting.
Pricing, market access, forecasting, customer analytics, and other commercial decisions all depend on reliable information about customers and organizations.
For instance, a team may use net price analytics DC to assess pricing performance and commercial economics. The analysis can be technically sound, but its usefulness still depends on the customer, account, and market information underneath it.
A data problem rarely stays in the data layer.
It eventually shows up in a decision.
That’s why HCP intelligence is increasingly becoming a commercial capability, not just something maintained for CRM or governance purposes.
Closing the Commercial Reality Gap
Closing the gap doesn’t mean trying to eliminate every inconsistency in the healthcare ecosystem. That’s not realistic.
The more practical goal is to shorten the distance between a change happening in the market and trusted intelligence becoming available to the people who need it.
That requires three pieces.
- Continuous validation Organizations need processes that identify and verify important changes as they happen instead of waiting for the next scheduled refresh.
- Connected systems Once a change is validated, it needs to reach CRM platforms, territory models, customer 360 environments, analytics systems, segmentation engines, and AI applications consistently. Otherwise, different teams end up working from different versions of the same customer.
- Business-focused governance Governance shouldn’t stop at asking whether a record meets a data-quality threshold. It should also ask whether the information is current enough to support the decision being made. Technology helps make this possible, but it isn’t the whole answer. Clear ownership, validation workflows, governance, and ongoing monitoring still matter. AI Readiness Starts With the Data Behind the Decision The next step in commercial AI isn’t just about building more sophisticated models. It’s about making sure those models have a current view of the customers and organizations they’re trying to understand. A company can have a modern AI stack, strong infrastructure, and an advanced targeting model. If its provider relationships are months out of date, the system is still working from yesterday’s market. That’s why intelligence agility is becoming so relevant. The organizations with an advantage will be the ones that can detect a meaningful change, validate it, and get that information into commercial workflows quickly. For commercial leaders, the better question may not be: “How accurate is our HCP data?” It’s: “When the market changes, how quickly does our commercial intelligence catch up?” That’s where AI readiness really starts.
Top comments (0)